glutamine and gc 1 compound

glutamine has been researched along with gc 1 compound in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adebayo Michael, AO; Calvisi, D; Chen, X; Görg, B; Häussinger, D; Ko, S; Liu, P; Liu, S; Moghe, A; Monga, JS; Monga, SP; Oertel, M; Poddar, M; Pradhan-Sundd, T; Qvartskhava, N; Ranganathan, S; Rebouissou, S; Ribback, S; Russell, JO; Singh, S; Singhi, A; Tao, J; Xu, M; Yang, H; Zucman-Rossi, J	1

Other Studies

1 other study(ies) available for glutamine and gc 1 compound

Article	Year
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations. Cell metabolism, 2019, 05-07, Volume: 29, Issue:5 Topics: Acetates; Animals; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Child, Preschool; Disease Models, Animal; Female; Glutamate-Ammonia Ligase; Glutamine; Hepatocytes; Humans; Infant; Liver Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Phenols; Retrospective Studies; Sirolimus; TOR Serine-Threonine Kinases; Transfection; Wnt Signaling Pathway	2019

Article

Year

Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.

Cell metabolism, 2019, 05-07, Volume: 29, Issue:5

Topics: Acetates; Animals; beta Catenin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Child, Preschool; Disease Models, Animal; Female; Glutamate-Ammonia Ligase; Glutamine; Hepatocytes; Humans; Infant; Liver Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Phenols; Retrospective Studies; Sirolimus; TOR Serine-Threonine Kinases; Transfection; Wnt Signaling Pathway

2019